APALUTAMIDE
Zydus Lifesciences gets USFDA nod to produce prostate cancer treatment drugZydus Lifesciences Ltd has received final approval from the USFDA to manufacture 60 mg Apalutamide tablets for prostate cancer treatment. T...18 Mar, 2025, 07.04 PM IST
BDR Pharmaceutical launches generic drug for treating prostate cancer in IndiaBDR Group Director Business Development Raheel Shah said that the launch of APATIDE is "testimony towards our commitment in providing acces...03 Jan, 2023, 03.33 PM IST
Load More